Magnolia Flower Teapills
On sale on the US market (according to the DSLD)
Plum Flower, food supplement from the US market
Magnolia Flower Teapills (Plum Flower), a food supplement au code-barres 739934833155, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Plum Flower
- Barcode
- 739934833155
- Form
- Tablet
- One serving
- « 8 Pill(s) »
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Dextrin, Magnesium Silicate, Hydrated, Carbon, Activated, China Wax
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Extract Blend | Blend | 1,360 mg |
| Magnolia biondii Flower Extract | Plant | not stated |
| Angelica dahurica Root Extract (Angelica dahurica) | Plant | not stated |
| Saposhnikovia divaricata Root Extract (Saposhnikovia divaricata) | Plant | not stated |
| Ligusticum sinense Rhizome, Root Extract | Plant | not stated |
| Cimicifuga heracleifolia Rhizome Extract (Actaea racemosa) | Plant | not stated |
| Akebia trifoliata Stem Extract | Plant | not stated |
| Ligusticum chuanxiong Rhizome Extract | Plant | not stated |
| Notopterygium incisum Rhizome, Root Extract | Plant | not stated |
| Glycyrrhiza uralensis Root Extract (Glycyrrhiza uralensis) | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Magnolia Flower Teapills
Entered into DSLD on 23 July 2020. Withdrawn from the US market on 23 March 2023 (according to the DSLD).- Active ingredient added : Akebia trifoliata extract (quantity not stated)
- Active ingredient added : Angelica dahurica extract (quantity not stated)
- Active ingredient added : Cimicifuga heracleifolia extract (quantity not stated)
- Active ingredient added : Glycyrrhiza uralensis extract (quantity not stated)
- Active ingredient added : Ligusticum chuanxiong extract (quantity not stated)
- Active ingredient added : Ligusticum sinense extract (quantity not stated)
- Active ingredient added : Magnolia biondii extract (quantity not stated)
- Active ingredient added : Notopterygium incisum extract (quantity not stated)
- Active ingredient added : Saposhnikovia divaricata extract (quantity not stated)
- Active ingredient removed : Akebia trifoliata Stem Extract (quantity not stated)
- Active ingredient removed : Angelica dahurica Root Extract (quantity not stated)
- Active ingredient removed : Cimicifuga heracleifolia Rhizome Extract (quantity not stated)
- Active ingredient removed : Glycyrrhiza uralensis Root Extract (quantity not stated)
- Active ingredient removed : Ligusticum chuanxiong Rhizome Extract (quantity not stated)
- Active ingredient removed : Ligusticum sinense Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Magnolia biondii Flower Extract (quantity not stated)
- Active ingredient removed : Notopterygium incisum Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Saposhnikovia divaricata Root Extract (quantity not stated)
- Different quantity per serving : Proprietary Extract Blend: 1,320 mg in this version; 1,360 mg on the displayed label
Official label: Magnolia Flower Teapills
Entered into DSLD on 21 November 2019. Withdrawn from the US market on 18 May 2020 (according to the DSLD).- Active ingredient added : Akebia trifoliata (quantity not stated)
- Active ingredient added : Angelica dahurica (quantity not stated)
- Active ingredient added : Cimicifuga heracleifolia (quantity not stated)
- Active ingredient added : Glycyrrhiza uralensis (quantity not stated)
- Active ingredient added : Ligusticum chuanxiong (quantity not stated)
- Active ingredient added : Ligusticum sinense extract (quantity not stated)
- Active ingredient added : Magnolia biondii (quantity not stated)
- Active ingredient added : Notopterygium incisum (quantity not stated)
- Active ingredient added : Saposhnikovia divaricata (quantity not stated)
- Active ingredient removed : Akebia trifoliata Stem Extract (quantity not stated)
- Active ingredient removed : Angelica dahurica Root Extract (quantity not stated)
- Active ingredient removed : Cimicifuga heracleifolia Rhizome Extract (quantity not stated)
- Active ingredient removed : Glycyrrhiza uralensis Root Extract (quantity not stated)
- Active ingredient removed : Ligusticum chuanxiong Rhizome Extract (quantity not stated)
- Active ingredient removed : Ligusticum sinense Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Magnolia biondii Flower Extract (quantity not stated)
- Active ingredient removed : Notopterygium incisum Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Saposhnikovia divaricata Root Extract (quantity not stated)
Official label: Magnolia Flower Teapills (Xin Yi Wan)
Entered into DSLD on 20 November 2017. Withdrawn from the US market on 26 February 2019 (according to the DSLD).- Active ingredient added : Akebia trifoliata (quantity not stated)
- Active ingredient added : Angelica dahurica (quantity not stated)
- Active ingredient added : Cimicifuga heracleifolia (quantity not stated)
- Active ingredient added : Glycyrrhiza uralensis (quantity not stated)
- Active ingredient added : Ligusticum chuanxiong (quantity not stated)
- Active ingredient added : Ligusticum sinense (quantity not stated)
- Active ingredient added : Magnolia biondii (quantity not stated)
- Active ingredient added : Notopterygium incisium (quantity not stated)
- Active ingredient added : Saposhnikovia divaricata (quantity not stated)
- Active ingredient removed : Akebia trifoliata Stem Extract (quantity not stated)
- Active ingredient removed : Angelica dahurica Root Extract (quantity not stated)
- Active ingredient removed : Cimicifuga heracleifolia Rhizome Extract (quantity not stated)
- Active ingredient removed : Glycyrrhiza uralensis Root Extract (quantity not stated)
- Active ingredient removed : Ligusticum chuanxiong Rhizome Extract (quantity not stated)
- Active ingredient removed : Ligusticum sinense Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Magnolia biondii Flower Extract (quantity not stated)
- Active ingredient removed : Notopterygium incisum Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Saposhnikovia divaricata Root Extract (quantity not stated)
- Different quantity per serving : Proprietary Extract Blend: 1,320 mg in this version; 1,360 mg on the displayed label
Official label: Magnolia Flower Teapills (Xin Yi Wan)
Entered into DSLD on 21 December 2012. Withdrawn from the US market on 6 October 2017 (according to the DSLD).- Active ingredient added : Akebia trifoliata (quantity not stated)
- Active ingredient added : Angelica dahurica (quantity not stated)
- Active ingredient added : Cimicifuga heracleifolia (quantity not stated)
- Active ingredient added : Glycyrrhiza uralensis (quantity not stated)
- Active ingredient added : Ligusticum chuanxiong (quantity not stated)
- Active ingredient added : Ligusticum sinense (quantity not stated)
- Active ingredient added : Magnolia biondii (quantity not stated)
- Active ingredient added : Notopterygium incisium (quantity not stated)
- Active ingredient added : Saposhnikovia divaricata (quantity not stated)
- Active ingredient removed : Akebia trifoliata Stem Extract (quantity not stated)
- Active ingredient removed : Angelica dahurica Root Extract (quantity not stated)
- Active ingredient removed : Cimicifuga heracleifolia Rhizome Extract (quantity not stated)
- Active ingredient removed : Glycyrrhiza uralensis Root Extract (quantity not stated)
- Active ingredient removed : Ligusticum chuanxiong Rhizome Extract (quantity not stated)
- Active ingredient removed : Ligusticum sinense Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Magnolia biondii Flower Extract (quantity not stated)
- Active ingredient removed : Notopterygium incisum Rhizome, Root Extract (quantity not stated)
- Active ingredient removed : Saposhnikovia divaricata Root Extract (quantity not stated)
- Different quantity per serving : Proprietary Extract Blend: 1,320 mg in this version; 1,360 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cimicifuga heracleifolia Rhizome Extract
Read the warning, when it applies and the studies cited
Black Cohosh - Actaea Racemosa
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder or develop symptoms of liver trouble (EMA 2018, 2007; Lynch et al. 2006; Mills et al. 2006; Cohen et al. 2004; NIH 2004).
Sources cited by Health Canada (6)
- Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause: the Journal of the North American Menopause Society 2004;11(5):575-577. PubMed Case report
- EMA 2018: European Medicines Agency. Committee on Herbal Medicinal Products (HMPC). European Union Herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizome. March 2018. [Accessed 2025 January 3]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf
- EMA 2007: European Medicines Agency. Committee on Herbal Medicinal Products (HMPC) Annex 1. Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (Black cohosh, root). London (UK): European Medicines Agency; May 20027. [Accessed 2025 January 3]. Available from: https://www.ema.europa.eu/en/documents/herbal-report/assessment-case-reports-connected-herbal-medicinal-products-containing-cimicifugae-racemosae-rhizoma-black-cohosh-root_en.pdf
- Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transplantation 2006;12(6):989-992. PubMed Case report
- Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. New York (NY): Taylor and Francis; 2006.
- NIH 2004: National Institutes of Health. Workshop on the Safety of Black Cohosh in Clinical Studies. Bethesda (MD): National Institutes of Health, Department of Health and Human Services; November 22, 2004. [Accessed 2024 December 3]. Available from: https://files.nccih.nih.gov/s3fs-public/news/blackcohosh_mtngsumm.pdf
Contraindications
Do not use if you are pregnant (Brinker 2010; Hoffmann 2003; Tilgner 1999).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
- Tilgner S. Herbal Medicine from the Heart of the Earth Creswell (OR): Wise Acre Press; 1999.
- Glycyrrhiza uralensis Root Extract
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M. editors. 2013. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. Boca Raton (FL): CRC Press.
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
Sources cited by Health Canada (1)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
Sources cited by Health Canada (2)
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- Gardner Z, McGuffin M. éditeurs. 2013. American Herbal Products Association's Botanical Safety Handbook, 2e édition. Boca Raton (FL): CRC Press.
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
Sources cited by Health Canada (4)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (UK): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2012. European Medicines Agency. Community Herbal Monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 22 May 2012. [Accessed 2024 January 6]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Plum Flower
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Magnolia Flower Teapills (Plum Flower): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/739934833155-magnolia-flower-teapills-plum-flower, updated 24 October 2024.